SK Bio­science takes ma­jor­i­ty stake in CD­MO for $244M; Ex-Lon­za CEO joins Cy­ti­va

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

SK Bio­science

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.